

Cover Story
NCI and the Children's Oncology Group opened enrollment in Pediatric Molecular Analysis for Therapy Choice—Pediatric MATCH—a long-awaited precision medicine trial.
In Brief


Drugs & Targets


Trending Stories
- NIH Director Jay Bhattacharya launches a podcast
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
- As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention
- “Forward funding” NIH budget plan would make competing for grants much harder
- In the Headlines: What if curing diseases was treated like a business?